Sen. John Boozman bought CVS Health (CVS)
Sen. John Boozman (R-AR) · $1K–$15K · traded Jan 29, 2026
- Transaction
- Bought
- Amount
- $1K–$15K
- Owner
- Joint
- Traded
- Jan 29, 2026
- Disclosed
- Feb 15, 2026
- Days to disclose
- 17
- Asset type
- Stock
- As filed
- CVS Corp
- Industry
- Medical - Healthcare Plans · Healthcare
Other trades in this filing
All of Boozman's trades →- Feb 15, 2026$1K–$15K
$1K–$15K · Traded Jan 29, 2026 · disclosed Feb 15, 2026 · Joint
- Feb 15, 2026$1K–$15K
$1K–$15K · Traded Jan 29, 2026 · disclosed Feb 15, 2026 · Joint
Committee overlap: Agriculture - Feb 15, 2026$1K–$15K
$1K–$15K · Traded Jan 29, 2026 · disclosed Feb 15, 2026 · Joint
- Feb 15, 2026$1K–$15K
$1K–$15K · Traded Jan 26, 2026 · disclosed Feb 15, 2026 · Joint
- Feb 15, 2026$1K–$15K
Bought iShares Core S&P 500 ETF IVV
$1K–$15K · Traded Jan 23, 2026 · disclosed Feb 15, 2026 · Joint
- Feb 15, 2026$1K–$15K
Bought Janus Henderson Mortgage-Backed Securities ETF JMBS
$1K–$15K · Traded Jan 23, 2026 · disclosed Feb 15, 2026 · Joint
- Feb 15, 2026$1K–$15K
Bought American Funds New World Fund Class R-6 RNWGX
$1K–$15K · Traded Jan 23, 2026 · disclosed Feb 15, 2026 · Joint
- Feb 15, 2026$1K–$15K
Bought Sprott Lithium Miners ETF LITP
$1K–$15K · Traded Jan 23, 2026 · disclosed Feb 15, 2026 · Joint
- Feb 15, 2026$1K–$15K
Bought Tortoise North American Pipeline ETF TPYP
$1K–$15K · Traded Jan 23, 2026 · disclosed Feb 15, 2026 · Joint
- Feb 15, 2026$1K–$15K
Bought Vanguard Global ex-U.S. Real Estate ETF VNQI
$1K–$15K · Traded Jan 23, 2026 · disclosed Feb 15, 2026 · Joint
- Feb 15, 2026$1K–$15K
Bought FT Energy Income Partners Enhanced Income ETF EIPI
$1K–$15K · Traded Jan 23, 2026 · disclosed Feb 15, 2026 · Joint
- Feb 15, 2026$1K–$15K
Bought First Trust Global Tactical Commodity Strategy Fund FTGC
$1K–$15K · Traded Jan 23, 2026 · disclosed Feb 15, 2026 · Joint
- Feb 15, 2026$1K–$15K
Bought Goldman Sachs ActiveBeta Emerging Markets Equity ETF GEM
$1K–$15K · Traded Jan 23, 2026 · disclosed Feb 15, 2026 · Joint
- Feb 15, 2026$1K–$15K
Bought Goldman Sachs Access Investment Grade Corporate Bond ETF GIGB
$1K–$15K · Traded Jan 23, 2026 · disclosed Feb 15, 2026 · Joint
- Feb 15, 2026$1K–$15K
Bought Invesco Short Term Treasury ETF TBLL
$1K–$15K · Traded Jan 23, 2026 · disclosed Feb 15, 2026 · Joint
- Feb 15, 2026$1K–$15K
$1K–$15K · Traded Jan 23, 2026 · disclosed Feb 15, 2026 · Joint
- Feb 15, 2026$1K–$15K
$1K–$15K · Traded Jan 23, 2026 · disclosed Feb 15, 2026 · Joint
- Feb 15, 2026$1K–$15K
$1K–$15K · Traded Jan 15, 2026 · disclosed Feb 15, 2026 · Joint
- Feb 15, 2026$1K–$15K
$1K–$15K · Traded Jan 15, 2026 · disclosed Feb 15, 2026 · Joint
Got $13K from the company’s PAC - Feb 15, 2026$1K–$15K
$1K–$15K · Traded Jan 8, 2026 · disclosed Feb 15, 2026 · Joint
Recent Congress trades in CVS
- Oct 7, 2026$15K–$50K
Rep. Ro Khanna (D-CA-17)
$15K–$50K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - May 11, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Apr 13, 2026 · disclosed May 11, 2026 · Spouse
- Feb 6, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Jan 29, 2026 · disclosed Feb 6, 2026 · Spouse
- Dec 19, 2025$1K–$15K
Rep. Dwight Evans (D-PA-3)
$1K–$15K · Traded Nov 21, 2025 · disclosed Dec 19, 2025
Committee overlap: Ways and Means - Nov 21, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
$1K–$15K · Traded Oct 31, 2025 · disclosed Nov 21, 2025 · Spouse
- Nov 21, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
$1K–$15K · Traded Oct 30, 2025 · disclosed Nov 21, 2025 · Spouse
- Nov 21, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
$1K–$15K · Traded Oct 30, 2025 · disclosed Nov 21, 2025 · Spouse
Company context for CVS
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
CVS: Shah Prem S reported buying shares
1 reported purchase of non-derivative securities. Code P includes open-market and private purchases; it does not establish motive.
CVS: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.
CVS: Company disclosure
Filed 8-K for an event or period dated 2026-11-04. Company disclosure.
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.